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Abstract
Diabetes is a condition that is primarily self-managed and lifestyle modifications
such as diet, exercise, and weight management are necessary to reduce morbidity and
mortality. Motivation to implement lifestyle modifications through self management is an
integral part of disease management and studies have shown group medical visits are
more effective than individual appointments in this patient population.
The purpose of this project was to develop, implement and evaluate an evidencebased group medical visit program for up to a maximum of 8 adult patients with type 2
diabetes in a family practice setting for six months. Seven participants with abnormal
A1C results accepted the invitation to attend group medical visits. Here surrounded by
peers with the same diagnosis, they were able to learn and discuss methods to self
manage their type 2 diabetes.
At the conclusion post survey results indicate positive change in some lifestyle
behaviors and improvement with hemoglobin A1C. However there was no improvement
in weight management. A cost analysis reveals group medical visits may generate a
small profit when compared to individual visits. Group medical visits may offer an
effective means to motivate patients to make lifestyle change to reduce risk.

Chapter One: Introduction
The number of patients diagnosed with diabetes is climbing at an alarming rate
and is considered to be epidemic by some experts. The Centers for Disease Control
(CDC, 2008) estimated the prevalence rate for diabetes in the United States at nearly 24
million or 8 percent of the population. This figure is up from the 2002 estimates of 18.1
million or 6.3% of the population. At first glance this increase may not seem so alarming
but the overall incidence of type 2 diabetes tripled from 1980 to 2006 with greater than
one third of the patients being 65 years or older (CDC, 2007a).
Type 2 diabetes accounts for 90 to 95 percent of all diabetes cases and
approximately one-third of patients are unaware they even have the disease. The National
Diabetes Information Clearinghouse (NDIC, 2005) estimates that approximately 54
million individuals have a pre-diabetic condition (impaired glucose tolerance or impaired
fasting glucose) that if left untreated will likely develop into diabetes within 10 years.
Health care costs associated with diabetes are quite significant. Medical
expenditures for diabetic patients are 2.3 times greater than non diabetics (American
Diabetes Association [ADA], 2007). The ADA (2007) estimated expenditures of $174
billion in 2007, of which $116 billion was spent on direct medical care. Hospitalizations
for diabetes related problems totaled 24.3 million days with $58.3 billion spent.
Outpatient care rates were the highest for diabetic patients and totaled $9.9 billion. There
were 15 million work absences and 120 million reduced performance workdays.
Approximately 107 million work days lost due to disability attributed to diabetes related

2
complications with 445,000 cases of permanent disability, a 32% increase or $42 billion
since 2002 (ADA, 2007).
Management of chronic conditions involves significant provider time with
education and counseling as well as time for pharmacological management (De Vries,
Darling-Fisher, Thompson, & Belanger-Shugart, 2008). Diabetes is a disease that is
primarily self-managed. Generally, patients should be seen 3 to 4 times a year and the
health care provider has limited time during traditional medical visits for patient
education. Motivation to implement lifestyle modifications through self management
education is an integral part of disease management to optimize glycemic control and
minimize complications (ADA, 2009). Group medical visits are an alternative care
delivery format that may improve outcomes in patients with chronic conditions (De Vries
et al., 2008). Group medical visits are a combination of three types of visit: individual,
education and support (Jaber, Braksmajer, & Trilling, 2005). Patients are given ample
time and opportunity with the provider and are surrounded by peers who are coping with
the same disease and many of the same issues. Listening to others who have the same
disease and problems that are empathetic and supportive can be the best change agent
(Powell, 2007).
Purpose
The purpose of this project was to develop, implement and evaluate an evidencebased group medical visit program for up to a maximum of 8 adult patients with type 2
diabetes in a family practice office for six months. Specifically, outcomes related to
behavior changes and clinical improvements were evaluated at baseline, 3 and 6 months
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after participation in group medical visits. Additionally cost of providing group medical
visits in private primary care practice was computed.
Definition of Terms
Diabetes self-management. For the purposes of this project, diabetes selfmanagement was defined as the cornerstone behaviors necessary for improved health
outcomes (Funnell et al., 2009). Diabetes self-management outcomes were measured
using five survey scales from the Stanford Patient Education Research Center (2008).
Scales selected for this project were eating breakfast, glucose testing, exercise, self
efficacy for diabetes, and communication with physicians.
Behavior change. Behavior changes are based on the American Association of
Diabetes Educators (AADE), outcomes standards (Tomky, Cypress, Dang, Maryniuk, &
Peyrot, 2008). Behavior changes are the adoption of identified activities that will improve
clinical outcomes and ultimately health status. Behavioral activities include exercise,
healthy eating habits, monitoring of blood glucose, and problem-solving.
Self efficacy. Self efficacy is an individual’s belief in their capabilities to
accomplish a specific task and affects their motivation to succeed (Bandura, 1994).
Clinical improvement. Clinical improvement was measured by a decrease in
glycated hemoglobin A1C, weight and body mass index (BMI).
Time. The time of the proposed project was six months once participants were
recruited and group medical visits began.
Program cost. An analysis of program cost was calculated using the amount of
time and resources for the group medical visit and compared to individual visits.
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Patient satisfaction. Patient satisfaction was defined as the liking and approval
participants have for their care provider. It was measured by the patient-provider
relationship, specifically their confidence in communicating with the provider.
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Chapter Two: Review of the Literature
This chapter will begin with an overview of Type 2 diabetes, its pathophysiology,
complications, treatment and prognosis. This will be followed by a discussion of the
concepts of group medical visits. The chapter will conclude with identification and
evidence related to the use of group medical visits in diabetes management.
Diabetes
Diabetes is a complex, chronic metabolic disorder characterized by elevated blood
glucose levels resulting from defects in insulin production or action (ADA, 2009; CDC,
2007b). There are three major classifications of diabetes, type 1 diabetes, type 2 diabetes,
and gestational diabetes. The focus of this discussion is on type 2 diabetes, the more
prevalent form of this disease.
Type 2 diabetes is an insidious disease that quietly progresses undetected for many
years as the clinical manifestations are often non specific (Hawkins et al., 2002).
Frequently the diagnosis is not made until complications appear or the patient is acutely
ill and seeks treatment (ADA, 2009). Based on established criteria, a diagnosis of
diabetes is made if a fasting plasma glucose is greater than or equal to 126 mg/dl on two
occasions; or if during an oral glucose tolerance test with a 75 gram glucose load, a two
hour post prandial test is greater than or equal to 200 mg/dl; or a casual glucose is greater
than or equal to 200 mg/dl in a symptomatic patient (ADA, 2009). Criteria to test for prediabetes and diabetes in asymptomatic patients has been established as the length of the
glycemic burden is a predictor of unfavorable outcomes and management exists to reduce
the risk of progression and complications of the disease.
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Pathophysiology. While the precise cause of type 2 diabetes is unknown, there are
many common risk factors that are linked to its development (Hawkins et al., 2002). The
most common are obesity and inactivity. Type 2 diabetes is characterized by insulin
resistance and impaired beta cell function (Cnop et al., 2007). During the early stage, the
body compensates by increasing insulin secretion. This stage of hyperinsulinemia may
last for many years before the appearance of hyperglycemia. Next there is impaired
regulation of hepatic glucose production with both overproduction and overuse of
glucose. A declining beta cell function will eventually lead to beta cell failure (Maitra &
Abbas, 2005).
Complications. Individuals with diabetes have an increased risk of death at a rate
of two times greater when compared to people without diabetes of similar age (CDC,
2007b). In 2006, diabetes was the seventh leading cause of death and contributed to
greater than three times as many additional deaths. It is believed these figures are
conservative as diabetes is likely to be under reported when patients have multiple
chronic conditions. The majority of deaths are the results of macrovascular complications
such as stroke and myocardial infarction (CDC, 2007b). The long term effects of diabetes
may be devastating since the disease process affects virtually every body system.
Complications associated with the disease are sobering, life altering and as mentioned
even life threatening. In a 24 hour period there are 4100 new cases, 810 deaths, 230 limb
amputations, 120 needing dialysis or transplant and 55 newly blind (Beckley, 2006). It is
estimated that 57.9% or three of five persons with type 2 diabetes have at least one other
serious associated medical problem (American Association of Clinical Endocrinologists
[AACE], 2007) (see Table 2.1). Recently the AACE (2007) has identified prevalence
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rates of macrovascular and microvascular problems in people with diabetes compared to
those without the disease (see Table 2.2).
Table 2.1
Diabetes Complications by System
System Affected
Cardiovascular

Complication

Heart disease
Stroke
Hypertension
Worsens hyperlipidemia
Peripheral artery disease
Eye
Blindness / Diabetic retinopathy
Dental
Periodontal diseases
Gastrointestinal
Gastroparesis
Genital Urinary
Diabetic nephropathy / End-stage renal failure
needing dialysis or transplant
Urinary incontinence in females
Erectile dysfunction in males
Musculoskeletal
Amputations
Diabetic foot wounds
Nervous System
Peripheral neuropathy
Complications of Pregnancy
Major birth defects
Spontaneous abortions
Fetal growth abnormalities
Fluid & Electrolyte
Electrolyte imbalance
Ketoacidosis
Other
More susceptible to other illnesses
Associated with worse prognoses
Premature death
From “National Diabetes Fact Sheet, 2007: General Information and National Estimates
on Diabetes in the United States,” by Centers for Disease Control and Prevention, 2007,
Copyright 2007 by the U.S. Department of Health and Human Services.

Treatment. The best defense against diabetes is prevention of the disease with
early life style modifications including diet, exercise, and weight control. The Diabetes
Prevention Program (Knowler et al. 2002) enrolled 3234 pre-diabetic patients and
randomly assigned them to one of three interventional groups: intensive program of
lifestyle modification, standard lifestyle recommendations plus metformin and standard
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Table 2.2
Prevalence Rates for Comorbid Complications
Problem

Prevalence among
Diabetics

Prevalence among
Non-diabetics

Macrovascular Problems
Myocardial infarction
9.8%
1.8%
Coronary artery disease
9.1%
2.1%
Congestive heart failure
7.9%
1.1%
Stroke
6.6%
1.8%
Microvascular
Chronic kidney problems
27.8%
6.1%
Foot problems
22.8%
10%
Eye damage
18.9%
Not Available
From “State of Diabetes Complications in America,” by
American Association of Clinical Endocrinologists, 2007,
State of Diabetes Complication in America: A Comprehensive
Report, p 4. Copyright 2007 by the American Association of
Clinical Endocrinologists.
lifestyle recommendations plus placebo. The intensive program of lifestyle modifications
consisted of a 7% weight loss, low fat, low calorie diet, 150 minutes of brisk exercise a
week coupled with some counseling and behavior modification activities. The study was
stopped a year earlier than expected because of a 58% reduction in the development of
diabetes with lifestyle changes over a three year period. The combination of lifestyle
recommendations and metformin resulted in a 31% reduction.
Early diagnosis and aggressive treatment are required to minimize complications.
Treatment of Type 2 diabetes includes lifestyle management. The ADA released their
revisions and updated evidence based standards in January 2009 (ADA, 2009).
Management includes medical care from a team approach with the patient assuming a
dynamic role as diabetes is primarily self managed. All patients need to attend initial
classes and updates as needed to be self sufficient. Self monitoring of blood glucose and
A1C measurements should be carried out with the frequency depending on the glycemic
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control, generally 2 to 4 times a year. Medical nutrition therapy and daily exercise are
fundamental to the management of diabetes.
The ADA (2009) recently addressed comorbid conditions in the prevention and
management of complications and clearly reaffirmed the need for treatment of
hypertension, hyperlipidemia and obesity. Also recommended were appropriate uses of
aspirin, statins, angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor
blockers (ARB). Other recommendations include smoking cessation, immunizations,
annual labs and exams. Lastly, hyperglycemia may be treated with a variety of
pharmacotherapy agents including oral medical and subcutaneous insulin (ADA, 2009).
Prognosis. The sequelae of complications can be delayed or prevented by intensive
glycemic control (Murphy, Chapel, & Clark, 2004). The results of the United Kingdom
Prospective Diabetes Study, a landmark study, and the largest and longest ever conducted
on type 2 diabetes, clearly demonstrated that lowering blood glucose levels decreased
complications (Genuth et al., 2002). The treatment groups received various
pharmacotherapies and the control group intervention was diet. The study answered many
questions regarding diabetes care and contributes to the basis for which the guidelines
used today are developed (Genuth et al.).
Clinical guidelines for adults with diabetes can be found at the National Guideline
Clearinghouse. Other sources of guidelines are the ADA and AACE. Essentially the
guidelines are all very similar. One difference is ADA recommends an A1C of < 7%,
while AACE recommends a goal of <6.5% (Clark, 2005). For fasting blood sugar, the
ADA recommends 70 to 130mg/dl, while AACE recommends <110mg/dl. For the two
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hour post prandial, the ADA recommends < 180mg/dl and AACE at 140mg/dl.
Recommendations for diabetes surveillance are listed in Table 2.3.
Behavior Change
Patients present to primary care for management of their chronic conditions.
Generally they are scheduled in 15 minute blocks of time. Providers ask questions,
examine and formulate diagnoses. With such limited time advice is given with only the
most important topics covered and often guidance is skimmed over (Magar, DabovaMissova, & Gjerdingen, 2006). When the patient returns for follow up, it is frequently
noted there has been little to no improvement and patients tend to be labeled as
noncompliant or not motivated.
Even though patients are told they need to modify their lifestyle and know the
consequences of not following the recommendations, many find it difficult to get started
or stick with the recommended changes (Haskard-Zolnierek, & Dimatteo, 2009). This
lack of compliance and adherence to the prescribed plan is often due to a lack of
motivation. The other problem is in these short visits, patients set goals to lose weight,
start exercising, or stick to a low fat diet but are not taught how to accomplish this (Riley
& Marshall, 2010).
Chronic conditions such as diabetes are significantly influenced by lifestyle
behaviors. To effectively change behaviors, the ADA recommends programs using a
combination of behavioral and psychosocial strategies as having improved outcomes
(ADA, 2009). Recognizing the need to provide knowledge and skill training to produce
change, the American Association of Diabetes Educators (AADE) developed an
evidence-based framework of seven self care behaviors with measurable clinical
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Table 2.3
General Recommendations for Type 2 Diabetes
Guidelines
A1C
Lipids
Other laboratory testing –
Renal, Liver, Thyroid,
SMBG
Exercise

Recommendations

Monitored 2 – 4 times a year depending on control and
stability
Monitored 2 – 4 times a year depending on control
Monitored annually or as needed

Optimal frequency in unknown, will vary to meet goals
Regular activity at least 150minutes / week of moderate
intensity with some strength resistance exercise
DSME
All should receive with a diabetes certified educator
Medical nutritional therapy
Limit saturated & trans fatty acids, high fiber foods
Obesity
Weight loss, low carbohydrate or low calorie diet up to
one year
Smoking
None, smoking cessation
Dilated eye exam
Monitored annually
Podiatry exam
Monitored annually
Dental exam
Monitored biannually
Neuropathy
Monitored annually
Immunizations
Kept up to date
Prevention & management
Risk stratification for cardiovascular disease; monitor
of complications
B/P at each visit and treat if indicated with ACE / ARB;
treat hyperlipidemia with statins; treat cardiovascular
risk with aspirin
From “Standards of Diabetes Care – 2009” by the American Diabetes Association, 2009),
Diabetes Care, 31, pp. S12-S54. Copyright 2008 by the American Diabetes Association.
improvement indicators for improved health. The seven behaviors include healthy
eating, being active, taking medication, monitoring, problem solving, healthy coping and
reducing risks (Tomky et al., 2008).
Motivating patients with chronic conditions presents many challenges for the health
care provider (Miller, 2005). It is extremely difficult to motivate patients to change a life
time of undisciplined behaviors and habits to modify and sustain a healthy lifestyle. Diet
and exercise have been identified as the most difficult to control (Nelson & Tuttle, 2007;
Sullivan & Joseph, 1998). Asking patients to make multiple changes at once may be
overwhelming. Selecting one goal and focusing on it encourages adherence and it will
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have a ripple effect (Powell, 2007). Patients must identify barriers, deal with the
ambivalence of change and adhere to lifestyle changes that can significantly prolong and
improve their quality of life (Miller, 2005).
As health care providers one of our goals should be to develop methods to
improve patient motivation. In the Clinical Guidelines on the Identification, Evaluation,
and Treatment of Overweight and Obesity in Adults, the National Institutes of Health
(1998) states it is the duty of the primary care practitioner to heighten a patient’s
motivation when such is perceived to be of significant benefit for risk reduction. Maclean
and Pound (2000) identified patient motivation as a way of explaining the differences in
outcomes of patients with comparable disease processes. Wilson (2004) found education
coupled with frequent provider contact leads to continued improvement in gylcemic
control.
Group Medical Visits
In the mid 1970s pediatrician, Martin Stein designed group medical visits as an
alternative format for well care visits. Finding these visits time consuming, inefficient
and repetitive, Dr. Stein liked the idea of providing anticipatory guidance and education
in the group setting. For greater than twenty years, Dr. Stein successfully led well child
group medical visits (Anderson, 2006).
An early study to compare well child care in group visits with traditional visits
found group visits to be highly acceptable (Osborn & Wooley, 1981). The study found
group visits provided more time per patient visit, provided increased explanation to
parents, had more well-child visits completed, greater satisfaction reported and had less
advice sought between visits (Osborn & Wooley). As the concept of group medical visits
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evolved, multiple variations developed. Some originated at the hands of managed care
and HMOs. Other models came from a desire to improve care in specific areas such as
with the elderly, chronic disease, or acute care situations.
Models of care. One popular model is the cooperative health care clinic (CHCC)
which was started by John Scott as a research project with the elderly in 1991 and has
become prototypical for other programs nationally. The CHCC was designed to focus on
high utilizing patients who have frequent contact with the system (Noffsinger & Scott,
2000). Scott reportedly found this particular population with multiple medical problems
had the same lifestyle issues and educational needs and found that by meeting with them
as a group he was able to answer all their questions and meet individual needs, something
that could not have been done if they had been seen individually (Cunningham & Blaser,
2004). The CHCC typically consists of five components: socialization, education, break,
question & answer, and one-to-one provider-patient time (Noffsinger & Scott). The
individual time at the group medical visit is brief; patients with more extensive issues are
seen in additional individual visits.
A newer version of this format, the high risk cohort model (HRCM) focuses on a
specific chronic disease process such as diabetes or coronary heart disease. It is designed
for patients of all ages (Masley, Sokoloff, & Hawes, 2000). Both of these types of group
medical visits offer more consistent continuity of care. Patients are invited to join based
on predetermined criteria. Generally these visits are scheduled for two to two-and-onehalf hours. Patients are assessed by a nurse, vital signs obtained and any specific point of
care testing is performed. Like the CHCC, patients in HCRM who need brief individual
or private evaluation may receive it while others are being checked in. For more in-depth
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issues a separate appointment must be made. The first few minutes are spent in welcome
and warm up. Then there is a short educational program, followed by group discussion,
questions and answers. Visits are on a monthly, bimonthly or quarterly basis (Jaber,
Braksmajer, & Trilling, 2006b).
Another model, the drop-in group medical appointment (DIGMA) was developed
in 1996 to address access to care issues (Noffsinger & Scott, 2000). This model allows
for any of the provider’s patients to attend. A variety of problems and issues can be
addressed. This type of group is more holistic in nature addressing psychological,
behavioral health and physical medical issues (Noffsinger & Scott, 2000). Even though
the groups are scheduled, they are dynamic and each visit may have a totally different
mix of patients. Patients seen generally have complaints of an acute nature or follow up.
Typically this group lasts about 90 minutes and equally involves both a health care
provider and psychologist. Similar to the other group medical visits, DIGMAs are not
meant to completely replace individual appointments, but to supplement them. Table 2.4
depicts the major characteristics of these models.
Search for the Evidence
An electronic search of multiple databases that included Pub Med, Medline,
CINAHL, EBSCO host, Ovid and Cochrane Database was enlisted. Search terms
included group medical visits, group visits, group appointments, shared visits;
motivation, lifestyle management, self efficacy, behavior change; diabetes. Initially the
hits recovered descriptive articles on how to get started on setting up group medical
visits, the advantages and what was needed. Multiple research studies were found and in
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Table 2.4
Characteristics of Three Models of Group Medical Visits
Characteristic
Model of Group Medical Care
Patient Population
Focus

CHCC
Set Population
Multiple problems,
high utilizing,
chronic conditions

DIGMA
Mixed Group
Multiple complaint
generally worried
well

Meeting
Led By

Monthly
Provider

Length
Membership

120 minutes
Invitation only

Weekly
Provider &
Behaviorist
90 minutes
Open group for any
of provider’s
patients

HRCM
Set Population
Disease specific
such as DM, HTN,
Well Baby,
Prenatal
Varies
Provider
2–2 ½ hours
Invitation only

CHCC = Cooperative health care clinic
DIGMA = Drop-in group medical appointment
HRMC = High risk cohort model
total 48 studies were reviewed. Of this, 23 were specifically related to adult diabetes and
group medical visits, the additional studies involved group medical visits but with
different patient populations such as pediatrics, mother-baby or chronic care. There were
41 descriptive articles on general information for group medical visits. A search for a
systematic review for group visits found a protocol for a review that remained incomplete
for a number of years (Epling, et al., 2004) and was withdrawn August 2010.
Efficacy of Group Medical Visits for Persons with Type 2 Diabetes
Group medical visits have been recognized as an innovative way of providing care
that is patient centered, timely and efficient in our changing health care environment
(Jaber, Brakemajer, & Trilling, 2006b). In situations when patients do not achieve the
desired goals of treatment, the ADA (2009) suggests intensification of the medical
regimen. The ADA recognizes there is not one best form of education or approach and
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that both group education and more frequent contact with the patient are effective
(Funnell et al. 2009).
Patients who have attended group medical visits have higher levels of satisfaction
with their care as demonstrated by satisfaction surveys (Beck et al., 1997; Bronson &
Maxwell, 2004; Campbell & Gosselin, 2007). This is not an unexpected finding as group
medical visits increase face to face time for patients and their healthcare providers (Beck
et al., 1997). In addition, meeting times are generally once a month instead of every three
to four months. At the beginning of group visits there are a few minutes for social
interaction which is frequently nonexistent in individual appointments and providers are
unhurried. Patients also benefit from improved interactions, time for more questions and
clarification of unclear information (Clancy, Yeager, Brown, Magruder, & Huang, 2003).
Patients receive care while in a relaxed atmosphere and receive support from other
patients and staff. They are more satisfied with their provider and have increased access
(Thompson, 2000). These factors may account for the increased level of trust in
providers.
Advantages of group medical visits include an improved quality of life for
patients. In one comparison of patients who participated in group medical visits, they
were found to have fewer visits to emergency departments, subspecialists and decreased
hospitalizations (Scott et al., 2004). In a set group, patients developed an installation of
hope from group dynamics, they learned skill building and as their knowledge level
increased, patients felt more comfortable in making decisions about their own care
(Carlson, 2003). Participating in group medical visits empowers patients to make
informed healthcare decisions (Group Health, 2001). Group support and modeling by
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peers may also promote self-efficacy (Jaber et al., 2006a). Participants have the
opportunity to share experiences and success with others, who understand what they are
going through. Group participants overall perceived better coordinated care and
community orientation (Clancy, Yeager, Huang, & Magruder, 2007).
Patients attending group medical visits exhibited higher adherence to the ADA
standards of care. In a study with diabetic patients, 76% of group medical visit
participants were compliant on nine of ten ADA items compared with 23% of the control
group (Clancy, Cope, Magruder, Huang & Wolfman, 2003). Group participants were
more likely to receive influenza and pneumonia vaccinations when compared with those
in traditional care and multiple studies demonstrate group medical visits are an effective
alternative to traditional individual appointments (Beck et al, 1997; Clancy, Cope,
Magruder, Huang, & Wolfman, 2003).
An improvement in A1C in participants attending group medical visits was
demonstrated by Trento et al., (2001, 2002, & 2004). In all control groups there was an
increase or worsening of A1C. Clancy, Yeager, Brown, Magruder, et al, (2003) however
found minimal differences in A1C measurements between the groups. This may be
related to the length of the study as Clancy, et al, evaluated the effects of group visits for
a shorter period of time, six months; while Trento et al., evaluated the effectiveness over
two, four and five years respectively. Demographically, participants were very similar.
In a five year continuation study, Trento et al., (2004) did a follow up to measure
diabetes knowledge, ability to problem solve, and perceptions of quality of life. Patients
in the intervention group perceived a higher quality of life and maintained improved
hemoglobin A1C, decreased BMI and increased HDL. While patients attending group
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medical visits have an increase in knowledge and ability to problem solve it does not
necessarily change behaviors. In a group diabetes medical visit, individual participants
increased the frequency of self monitoring of blood glucose yet the proportion of patients
monitoring did not increase (Sadur et al., 1999).
For health care providers, group medical visits have proven to be very rewarding.
It has freed up appointment slots improving access for other patients. There is increasing
evidence that group medical visits are an effective way of managing patients with chronic
conditions (ADA, 2009). As there is increased pressure on health care providers to be
more productive, this method may help relieve some of the stress and pressure (Barud,
Marcy, Armor, Chonlahan, & Beach, 2006). Group medical visits have increased
productivity as much as 31% a month in some instances (Bronson & Maxwell, 2004).
There is decreased boredom and burn out.
While the advantages out weigh the challenges for group medical visits, several
issues need to be addressed. While patients and insurance plans need to be billed for
services, most including Medicare do not have a specific group visit code. Group visits
may be billed as individual office visits appropriate to the level of care provided, not for
time spent (Bronson & Maxwell 2004). Confidentiality must be addressed with
participants and agreements should be signed. Another issue that may lead to group
failure is high drop out rates or low group census. The more often the group visit the
better the attendance rate (Jaber et al., 2006a).
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Chapter Three: Methods
This chapter will include a description of the methods including the design,
setting, sample and procedures for the study. This will be followed by a discussion of the
feasibility, data analysis plan and protection of human subjects.
Study Design
Using a high risk cohort model, this project allowed up to eight adult patients with
uncontrolled type 2 diabetes to participate in group medical visits for six months to
determine if attending group medical visits in place of traditional individual visits
improves outcomes and reduces cost. The goal was to facilitate self management by
conducting monthly group medical visits. Patients were enrolled as they responded to
advertisement of the program and would potentially benefit from more intensive
management and support than they were currently receiving in individual visits.
Setting
The setting for the study was a family practice office in a large city in the
Southeastern United States. The office was staffed with two board certified family
medicine physicians, however one left during the time of this project. There were
approximately 4000 patients in this practice, approximately 5% of whom have type 2
diabetes. Patient payer mix is primarily through private insurance with approximately
10% self pay. This office setting was selected to conduct the project at the invitation of
the physician medical director / owner of the practice. While attending a local program
on group medical visits, the physician expressed an interest in conducting group medical
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visits but was not at a point to begin. She offered her office and any assistance so this
project could be accomplished.
The intended population for this project was adult patients with uncontrolled type
2 diabetes. The designated meeting area was a private conference room with a large table
and surrounding chairs. The room had a separate entrance and restroom from the rest of
the medical office practice,
Sample
Eight adult patients with uncontrolled type 2 diabetes diagnosed for at least six
months were recruited for this project. Uncontrolled diabetes was defined as having an
A1C >7.5%. Patients who were terminally ill, immobile, had mental or memory
problems, were severely hearing impaired, or who were non English speaking were
excluded. Patients were not excluded based on pharmacotherapy for diabetes (oral
diabetes medication(s) and/or basal insulin) or for comorbid conditions.
Procedures
To advertise the practice change, letters and posted signs were made available in
the waiting room and exam rooms. A list of current patients with the appropriate
diagnosis code was generated to help identify potential candidates. Letters were sent out
to all potential participants inviting them to attend approximately one month before the
first scheduled group visit (see Appendix A). The identification of potential participants
and recruitment was conducted by the physician providers in the office who invited the
patients to attend. The day prior to the visit, patients were called by the office staff to
confirm and remind them of the appointment. One medical assistant was specifically
working on this project for consistency.

21
Once a patient agreed to participate by signing a consent form, the chart was
reviewed by the physician and baseline laboratory testing requested. If there were current
lab results less than 30 days old, they were used in lieu of obtaining a new set as
insurance may not pay. Patients were provided with a packet of information that
explained the concept and the process of group medical visits (see Appendix B).
Baseline demographic data was obtained from the chart on all patients that
included date of birth, sex, race, martial status, education completed, type of insurance,
and occupation. Assessment data was collected at the initial visit and at each subsequent
visit and included weight, BMI, waist circumference, blood pressure, heart rate,
respiratory rate, and blood glucose. Laboratory and assessment data was entered into a
computerized data base by the office staff (see Appendix C for data entry form).
If the invitation was accepted, the patient switched from individual appointments
to group medical visits for diabetes care only. Other issues, acute problems and annual
exams needed to be scheduled as individual appointments.
Group Medical Visit Intervention
Group medical visits were scheduled on a monthly basis on the same day and at
the same time for a six month period. Patients were scheduled to come in 15 minutes
prior to the designated start time. The first 30 minutes were scheduled for check in which
consisted of bringing patients back to the check in station; obtaining a full set of vital
signs, weight, and finger stick blood glucose. One medical assistant was designated to
assist with the check in. The nurse practitioner completed a brief mental status,
cardiovascular, respiratory, skin and neurovascular exam in a private exam room. As
each patient was completed, they returned to the meeting area to wait where magazines
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and other educational materials were provided. Once everyone was checked in, a brief
warm up or socialization took place. For the first few visits, the focus was on having
participants get to know one another. The patient education segment was determined by
the group. A list of recommended patient education topics were provided to participants.
Topics included the basics such as physical activity, foot care, lipid management, food
preparation, or ADA guidelines. After a brief break, discussion questions that referred
back to the education topic were discussed. As a group, participants were able to decide
on next month’s topic before leaving (see Appendix D for the agenda and list of
education topics). At the end of each visit, there was a short amount of time available for
private consultation or evaluation if needed.
At each visit, after data were collected a report card with current medications,
yearly screening activities, any new laboratory results, and vitals signs from the current
visit were provided to the patient. Patients were encouraged to review the report and post
it on an obvious spot such as the refrigerator as a visual cue (see Appendix E).
Evaluation Plan
Hemoglobin A1C levels were measured at baseline, at 3 and at 6 months.
Anthropometric measurements of weight, body mass index (BMI), and waist
circumference were evaluated at baseline and at monthly visits. A survey of diabetes selfmanagement was administered at baseline and at 6 months.
Hemoglobin A1C. A1C levels were evaluated using the laboratory designated by
the patient’s individual insurance. As A1C has become the gold standard for assessing
and monitoring glycemic control, all laboratories determining this value should use
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method certified by the National Glycohemoglobin Standardization Program (Goldstein
et al. 2004.
Weight. Weight was measured by using a digital scale with participants removing
all excess clothing.
BMI. Body mass index was calculated using published charts after obtaining
weight (NIH, 2008).
Waist measurement. Waist circumference was measured by placing a tape
measure around the bare abdomen just above each participant’s hip bone. The tape was
snug but not compressing the skin and will be parallel to the floor. Participants were
instructed to relax, exhale, and waist measurement was obtained (NIH, 2008).
Diabetes self-management. Diabetes related behaviors and self efficacy were
measured using survey scales from the Stanford Patient Education Research Center
(2008). This center is well recognized for developing, adapting, and testing selfadministered scales over the past 20 years for chronic disease research. Funding for the
development of the scales was provided by the National Institute of Nursing Research.
The scales are free to use for research without permission. Scales selected for this project
were eating breakfast, glucose testing, exercise, self efficacy for diabetes, communication
with providers (see Appendix F).
Scoring was based on the number circled. If two consecutive numbers are circled,
the lower number is selected. If the numbers are not consecutive, they are not scored. If
more than two items are missing, the section is not scored. The self-efficacy and
communication scales may be summed for a total score. A higher total score indicates
higher self-efficacy or better communication with providers. These tests have been
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validated by previous subjects with diabetes (see Table 3.1 for characteristics of validity
and reliability).
Table 3.1
Characteristics of Validity and Reliability for Stanford Scales
Scale

Number of
Items

Range

Internal
Consistency

Test-Retest
Reliability

Breakfast
Ate Breakfast
1
0–7
N/A
N/A
Ate Protein
6
0–1
Glucose
Have Machine
1
0–1
N/A
N/A
Days Tested
1
1–7
Exercise
Minutes / Week
Stretching
1
0 – 180
N/A
0.56
Aerobic
5
0 – 540
N/A
0.72
Self Efficacy
8
1 - 10
0.828
N/A
Communication
3
0-5
0.73
0.89
From “Self-Management Scales” by the Stanford Patient Education Research Center,
2008. http://patienteducation.standford.edu/research/
At the last group medical visit, only three participants were in attendance. In an
effort to collect missing post survey data, an amended IRB application was submitted to
obtain approval to contact the absent participants for data completion. Once approval
was obtained, the remaining four participants were contacted and post survey data
collection was conducted over the phone.
Cost/Reimbursement. There are no billing codes for group visits and it is
unknown if insurance, Medicare or Medicaid will reimburse for the frequency of these
visits. Documentation and billing for services occurred as usual based on the level of
complexity and care for each individual and not the time spent in group medical visit.
Documentation required for billing purposes was met as it included vital signs, past
medical history, physical exam, and prescribed interventions. If insurers do not pay, the
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office forgave fees during the course of this project. However this is a medical visit and
was treated as such. Patients were informed in advance they were expected to make their
copay as usual at each visit.
A cost analysis was completed for group visits for the practice at the completion of
the project. As routine visits are scheduled at 15 minute intervals a comparison of
provider time for group medical visits versus individual visits will determine if income
has been generated to the practice. Results will be dependent on consistent attendance of
participants.
Data Analysis
Data collection was conducted with the assistance of one office medical assistant
designated for the project. All raw data was checked for errors. Analysis of data was
computed on SPSS version 16.0 software and a P value of <0.5 was selected to indicate
statistical significance. For evaluation of internal consistency on the self-efficacy and
communication scales, Cronbach’s coefficient alpha was used to test reliability. A paired
sample t-test, pretest – posttest format was used to evaluate the difference between
individual visits and group medical visits in a comparison of A1C, weight, BMI, and
waist circumference. A comparison of pre and post self management behaviors (eating
breakfast, glucose testing, exercise, self efficacy and communication) was evaluated
using the Wilcoxon rank sum nonparametric test. Due to the small sample size, more
complex analyses were not able to be performed.
A descriptive analysis compared group medical visits and individual visits in
terms of cost and revenue generated. Costs to the practice included an evaluation of
personnel time spent in preparation as well as the actual visit. Anticipated preparation
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time included call reminders and data collection. Revenue was evaluated based on the
coding charges and the amount reimbursed.
Protection of Human Subjects
IRB application was submitted to the University of North Florida IRB and
approved to conduct this project. Consent and a pledge to support were also obtained
from the physician’s office where group medical visits were conducted. Patients were
provided information and consent forms that explained attendance is voluntary, as is
sharing of information (see Appendix G). The patient had the option to opt out and return
to individual visits at any time.
Each person was required to sign a confidentiality agreement before and at each
visit as a reminder. The confidentially statement (see Appendix H) recognizes all medical
and personal information is confidential and that while they may discuss what was
learned they should never discuss any information about individual group participants.
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Chapter Four: Data Analysis
This chapter describes the project participants and results. Hemoglobin A1C as
well as pre and post self management behaviors (eating breakfast, glucose testing,
exercise, self efficacy and communication) were longitudinally evaluated. Descriptive
statistical analysis was conducted using SPSS version 16 statistical software and a P
value of < .05 was used to determine significance.
To identify potential participants for group medical visits a list was generated of
all patients with type 2 diabetes mellitus and their respective A1C. The list was reviewed
and 83 patients were found to have an abnormal A1C. Invitational letters were sent to
prospective patients with an A1C>7.5 approximately four weeks prior to the first group
medical visit. Replies were received via email and by phone calls within a week of the
letters going out. Packets were mailed out to all who expressed an interest and met the
criteria. Two days prior to the group medical visit, phone calls were made to remind
prospective participants of the upcoming visit. There were additional inquiries from
other patients after seeing the flyers posted in the office, however none met the criteria.
Implementation
This project began with nine patients who attended the first group medical visit.
After obtaining the initial data and assessment, the visit began with introductions and an
ice breaker to help participants relax. A discussion of the purpose and intent of the visits
helped clarify any misperceptions. At this visit ground rules and expectations were
established. A message board was provided for parking lot items and patients were
given permission to write their own questions on the board prior to or after each visit. At
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the close of each visit, patients were given a homework assignment and at the beginning
of the next visit it was briefly discussed to reinforce information previously
given/learned. In anticipation of the second visit, patients were asked to return with a
two day meal diary.
“Eating and Diabetes: The Food Pyramid” was the topic at the second visit.
Educational information presented started out with general healthy eating. Next a
comparison of the food pyramid was made with the diabetes food pyramid. Each section
was discussed in terms of foods in that group and how much should be eaten. Methods to
satisfy a sweet tooth and alcoholic drinks were also discussed. Patients were taught a
method to estimate a cup (fist), ½ cup (½ fists), and an ounce (cupped hand) and so on.
Carbohydrate counting was also discussed however it is noted none of the participants
use this method. At the close of the visit, participants were provided with work sheets to
review their own meal plans and see if they were meeting the guidelines and where
improvement could be made. A new member joined the group.
“Diabetes and Exercise” was the topic of the third group medical visit. The benefits
of exercise, the best exercise for individuals with diabetes and general exercise guidelines
were discussed at length. Various pieces of exercise equipment such as resistance bands
and hand weights were demonstrated. Pedometers were provided to those who did not
have one. A couple of participants already had one however they were not used in a
while. Education was provided on low blood glucose in relationship to exercise and
when to monitor. Exercise frequency and cautions were also addressed as well as the
issue of weather and heat related issues. Before leaving, “Barriers to Being Active Quiz”
(CDC, 2005) was given to each participant.
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At the fourth group medical visit, each participant was provided with a copy of
their latest lab results from their chart. Focus was on routine labs such as metabolic
panel, urine creatinine, hemoglobin A1C and lipids. Each test was discussed in terms of
what it was measuring and implications if it was out of range. For some, this was the first
time they had access to their entire lab results at one visit. Homework for this visit was
to review labs and return with any unanswered questions.
Standards of Medical Care in Diabetes were discussed at the fifth visit and the
value in meeting the guidelines. Emphasis was placed on general recommendation for
patients with type 2 diabetes which included A1C, other lab testing (lipids, renal, liver,
thyroid), self managed glucose testing, exercise, weight management, smoking, dilated
eye exam, podiatry exam, dental exam, immunizations, diabetes self management skills
and medical nutritional therapy. For homework patients were encouraged to make
appointments to complete recommendations if not up to date.
At the sixth and last visit a review of topics from the previous five visits was
conducted. Jeopardy type boards were fixed with the categories and points were
assigned. While this last visit was small, all participated and selected categories and
reviewed questions. Participants openly discussed things they learned over the course of
six months of group medical visits.
During the first visit, participants were generally reserved but during the second
and subsequent visits they were much more engaged with each other and the topic. All
participants expressed interest in learning about their disease and candidly discussed their
personal experiences and how things affected them. Many questions were asked and
although some things were not directly related to diabetes all were pertinent. Other
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discussions included hypoglycemia, arthritis, depression, co-morbid conditions, leg
cramps and family issues. When some of the topics were discussed, many would nod in
agreement indicating they had experienced the same thing. These common bonds helped
the group become comfortable with one another and open up.
At the last visit, only a few participants were in attendance. An amended
application was resubmitted to the IRB to obtain approval to contact the absent
participants. Each was contacted by either myself or the office medical assist in
collecting the missing survey data.
Demographics
Group medical visits were conducted monthly for a period of six months starting
in April 2010 and ending in September 2010 from 1:30 to 3:30. Initially, nine patients
expressed interest in the concept of group medical visits and accepted the invitation to
attend. A tenth patient joined the group at the second visit. Of that group a smaller core
group (n=7) attended visits regularly thereafter. Each patient signed the informed
consent form prior to participation in the group medical visits. All respondents met the
criteria of uncontrolled type 2 diabetes mellitus (A1C> 7.5%) with an established
diagnosis for at least six months. All were on oral diabetes medication and two had
additional basal insulin in their medication regimen. All had other comorbid diagnoses
such as hypertension, hyperlipidemia and coronary artery disease.
Of the ten enrolled participants, two attended all six group medical visits. One
attended five, two attended three, two attended two and three attended one. Monthly
attendance is presented in table 4.1. However, for purposes of this project, data analysis
was completed on participants who attended two or more group medical visits.

31
Table 4.1
Monthly Attendance
Month
April
Participants
9

May
5

June
5

July
5

August
6

September
3

Participants were between the ages of 51 and 75 with a mean age of 63.6 years.
The group consisted of three males (42%) and four females (57%). All participants were
Caucasian. Four participants were married; three were widowed, divorced or single.
Two (28%) participants completed college with one having a bachelor’s degree and the
other a master’s degree. The additional 72% completed ‘some’ college. One participant
was currently employed and the remaining listed retired or semi-retired as occupation.
All had a payer source with 57% private insurance and 43% through Medicare. There
were no significant differences in demographics for those that attended the initial visit but
did not complete the project. Demographics for the group were similar to the office
practice in general. Baseline demographics are presented in table 4.2.
Table 4.2
Baseline Demographics
Participant Age Sex
1
66
M
4
65
M
5
75
F
6
70
F
7
57
M
9
61
F
10
51
F

Race
C
C
C
C
C
C
C

Status
Single
Married
Divorced
Widowed
Married
Married
Married

Education
Some College
Some College
Some College
Some College
Master’s
Some College
Bachelor’s

Insurance
Medicare
BCBS
Medicare
Medicare
Humana
BCBS
BCBS

Occupation
Semi Retired
Retired
Retired
Retired
Retired
Retired
Floral Manager

During the project interval, no participants had any emergency department visits or
hospital admissions. One participant had an additional appointment for a urinary tract
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infection and another for bronchitis. None of the participants requested individual
diabetes appointment during the project.
Data collection
Assessment data collected at each visit included weight, BMI, blood pressure, heart
rate and respiratory rate. Random blood glucose was obtained at each visit except one as
the office ran out of test strips. Waist circumference was obtained at the initial and the
last visit instead of at each visit at the request of participants. Baseline measurements
obtained at the initial and completion visits are presented in table 4.3. Each participant
was provided assessment information obtained at each visit. Changes were calculated by
subtracting baseline values from the project completion values.
Table 4.3
Mean Baseline to Completion Measurements
Measurement
Initial
Completion
Weight
196.6
197.6
BMI
30.7
30.9
Waist Circumference
42.6
42.5
Systolic
135
121
Diastolic
76
62
Random Blood Glucose
183
154
Heart Rate
72
71
Respirations
18
18

Change
+1
+0.2
-0.1
-14
-14
-29
-1
No Change

Hemoglobin A1C
Baseline hemoglobin A1C values were obtained from the patient’s medical record
to insure they met the criteria for project inclusion (A1C>7.5). Participants were
provided lab slips by the provider to obtain A1C levels at 3 and 6 months. All
participants were compliant in having their labs drawn as requested at 3 months and 6
months with the exception of one participant who left the practice due to a change in
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insurance. All participants demonstrated improvement from baseline to three months and
from baseline to six months excluding the one participant that left the practice whose
results are unknown.
Table 4.4
Hgb A1C
Participant
01
04
05
06
07
09
10

Baseline
7.6
7.6
10.9
7.5
7.6
7.6
16.5

3 months
7.0
6.3
10.2
7.5
7.6
6.7
9.6

6 months
7.0
6.9
7.7
7.0
7.1
6.9
Left Practice

Five out of seven participants (71%) had a lower A1C at 3 months and the other two
participants showed no change. Table 4.4 presentsA1C values at baseline, 3 and 6
months.

18
16
14
12

Baseline

10

3 Months

8

6 Months

6
4
2
0
1

4

5

6

7

9

10

Figure 4.1. Individal paired comparison of A1C
At six months, all participants had a lower A1C than baseline and 4 out of 6 (57%) met
the ADA goal of <7%. Wilcoxon signed rank test shows statistical significance (P =
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0.031). Figure 4.1 depicts individual paired comparison of A1C over the six months of
group medical visits. The group mean was 9.3 at baseline and decreased to 7.8 and 7.1 at
three months and six months respectively.
Diabetes self-management
Diabetes related behaviors of eating breakfast, glucose testing, exercise,
communication with provider and self efficacy were measured and scored at baseline and
at the completion of the project to determine if there was an increase in self management
behaviors. Overall results from paired t-test for self efficacy, communication with
provider, exercise and eating breakfast indicate there are no significant differences from
baseline to end of study. See Table 4.5 for summary.
Table 4.5
Paired Samples Test for Self Management
Paired Differences
95% Confidence
Interval of the Difference
Sig. (2T
df tailed)
Lower
Upper
Pair 1 self BL - self EOS
-3.96
1.10
-1.38
6 0.22
Pair 2 comm BL - comm EOS -0.22
0.41
-1.68
6 0.14
Pair 3 EX BL - EX EOS
-0.87
0.31
-1.18
6 0.28
Pair 4 Eat BL - Eat EOS
-0.22
0.08
-1.19
6 0.28
self BL = Self Efficacy at base line
self EOS = Self Efficacy at end of study
comm. BL = Communication at base line comm. EOS = Communication at end of study
EX BL = Exercise at base line
EX EOS = Exercise at end of study
Eat BL = Ate Breakfast at base line
Eat EOS = Ate Breakfast at end of study

Eating Breakfast. While statistical significance related to behavior changes was
not demonstrated, on an individual basis there were some positive changes. In response
to the question related to eating breakfast, initially three of seven participants did not eat
breakfast each day the previous week. At completion all responded they had eaten

35
breakfast each of the previous seven days. In addition, the number eating protein for
breakfast increased.
Exercise. Exercise behaviors focused on type of exercise such as stretching,
strength training or aerobics and amount of total time spent on these activities in the past
week. Baseline results reveal three of seven participants did not engage in any exercise
activity. At the conclusion of the project all seven reported some exercise even though
those already exercising did not build on what they were doing. The time spent in
exercise was minimal. Refer to Table 4.6 for summary of exercise type and time.
Table 4.6
Exercise Type / Times a Week
Participant
Baseline
01
Stretching <30 minutes

End of Study
Walking 30-60 minutes

04

Stretching <30 minutes;
Walking >3 hours

Stretching 30-60 minutes;
Walking 1-3 hours

05

None

Stretching <30 minutes

06

None

Stretching <30 minutes;
Walking<30 minutes

07

None

Stretching 30-60 minute;
Walking 1-3 hours

09

Bicycling 1-3 hours;
Walking >3 hours

Walking 30-60 minutes

10

Stretching <30 minutes;
Swimming <30 minutes

Stretching 30-60 minutes;
Walking 30-60 minutes

Patient satisfaction. Survey questions for communication with provider asked if
participants prepared a list of questions, questioned things not known or understood and
if personal problems were discussed. Scoring was based on a 5-point Likert scale
ranging from ‘never to always’. Participants either stayed the same or improved except
for one participant who reported less communication at the end of the project. See table

36
4.7 for summary. It is unknown why one participant felt they had less communication
with their provider. During the group medical visits all participated and asked many
questions. Some would write on the parking lot board and others would bring their
questions written at home. All topics were discussed openly and respectfully.
Table 4.7
Communication with Provider (on Likert Scale 1-5)
Participant
Baseline
End of Study
01
3.4
4.7
04
3.4
4
05
1.3
2.7
06
1.7
5
07
3.4
2
09
4
4
10
3
4

Change
+1.3
+0.6
+1.4
+3.3
-1.4
0
+1

Self efficacy. As a means of measuring confidence levels, the self efficacy scale
focuses on diet, exercise, blood glucose and general care in terms of knowing how to
manage and when to seek additional support. Scoring is based on a 10-point Likert scale
ranging from ‘not at all confident to totally confident’. At the start, scores reflected
participants’ feelings of being ‘somewhat confident’. At completion, five out of 7 (71%)
participants’ scores suggest an incremental increase in confidence levels.
Table 4.8
Self Efficacy (on Likert Scale 1-10)
Participant
Baseline
01
7.9
04
8.8
05
3.6
06
5.1
07
5
09
6.8
10
7.3

End of Study
5.5
10
10
6.9
6
9.4
6.6

Change
-2.4
+1.2
+6.4
+1.8
+1
+2.6
-0.7
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For the participants with a decrease in their confidence to manage, one was slightly less
and the other just over 20% less. For this participant it is unclear why they felt less
confident because in attending group medical visits their knowledge level would increase
and in turn their ability to manage and make decisions would increase.

See Table 4.8

for summary.
Glucose testing. At the start of the project, two of the seven participants did not
own blood glucose meters and only one participant reported testing their blood glucose
level on a daily basis. At the conclusion, the two participants still did not have blood
glucose meters. Glucometers were offered free of charge several times and both declined
saying they “would not use them”. Of the seven participants, three reported checking
their blood glucose daily, one twice in the past seven days and one only once. See table
4.9 for summary. Two participants had a significant increase in blood glucose self
monitoring.
Table 4.9
Has a Meter/Number of Days Checked Blood Glucose Past Week
Participant
Baseline
End of Study
01
Yes / 2
Yes / 2
04
No / 0
No / 0
05
Yes / 7
Yes / 7
06
Yes / 1
Yes / 1
07
Yes / 0
Yes / 7
09
No / 0
No / 0
10
Yes / 2
Yes / 7
Cost/Reimbursement
At the completion of the project, an analysis of cost/reimbursement was conducted
to determine if this was a financial benefit for the office practice. In evaluating cost, it is
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noted some things are needed for both group medical visits as well as traditional visits
such as calling to remind patients of visits, check in procedures and obtaining random
blood glucose on diabetic patients. What is different is the assistance of the medical
assistant during the group medical visit and also the initial steps to prepare for the visits
by the nurse practitioner.
Since this was the first time this type of visits were conducted, prep time was
considerably longer than if they were ongoing. Prep time for each month was
approximately six to eight hours. Costs were evaluated in terms of time spent preparing
for the group medical visit, personnel needed and supplies used.
Table 4.10
Cost / Reimbursement
Initial Cost
Posters (2)
Office Supplies – paper, envelopes
Stamps, mailings
Bottled water, snacks
NP prep time (50 hours)
MA prep time (3 hours)
Test Strips (free)
Total

GMV
$18
$35
$75
$30
$2250
$45
0
$2453

Traditional

Routine Cost
NP time – 2.5 hours X 6months
MA time – 2.5 hours X 6 months
Total

$675
$225
$900

$675
$225
$900

Reimbursement
Average billing code
Number of visits from 1:30 – 3:30, April - September
Total

99214
33 X $138
$4,554

99214
36 X $138
$4968

Reimbursement was established by revenues generated by billing codes for patients
attending group medical visits. Billing codes were essentially the same as patients
attending group medical visit met the criteria for a moderate visit code. This was
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compared with revenues generated by the number of patients seen individually during the
same time frame. Results indicate group medical visits initially will require some upfront
cost but it is believed that as they are ongoing, they will be equitable and possibly even
make a small profit when compared to traditionally scheduled patients. See Table 4.10
for comparison or cost and reimbursement.
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Chapter 5: Discussion
This chapter provides a discussion of the implementation of group medical visits,
relevant findings, and lessons learned in the process. Limitations, implications for
practice and recommendations for future practice are also discussed.
Discussion
With an estimated 1.9 million adults diagnosed with diabetes in 2010 the
incidence is at an all time high (CDC, 2011). Less than fifty percent of patients fail to
meet ADA recommended goals (AACE, 2009). With the risk of significant
consequences from poorly controlled disease management, it is vital for healthcare
providers to find ways to motivate patients to make behavioral changes to effectively self
manage their diabetes. In the current economical climate, health care providers are under
increasing pressure to be more productive.
The purpose of this project was to develop, implement and evaluate an evidencebased group medical visit program for six months to determine if this intervention will
have a positive effect on outcomes related to behavior changes and clinical status.
Additionally, cost of providing group medical visits in private primary care practice was
evaluated. In previous studies used to evaluate group medical visits, participants came
from indigent backgrounds. This project was conducted in an office setting where the
majority of patients maintain insurance.
Results of this project demonstrated improvement in A1C levels for all
participants. Significantly 57% were able to meet the ADA goal of 7, at three months
and 83% at six months. While all did not meet goal, all reduced their risk of
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cardiovascular events. Thirty four percent of participants had significantly more risk as
their A1Cs were greater than ten.
Disappointingly self management behaviors while improved did not demonstrate
significant improvement. As this sample population was older it is unknown if results
would have been more significant for a younger patient group who would generally be
physically more able to exercise or feel they have increased satisfaction as the patientprovider relationship is more accessible and open to communication with their healthcare
provider. Results of this project found while not perfect, group medical visits offer an
opportunity to bridge the gap that is missing in individually scheduled visits.
Limitations
There were limitations to this project that have been identified. Differences
between pre and post surveys reveal some incremental positive changes for some patients
while others did not improve. In a systematic review, Riley and Marshall (2010)
identified current group visit methods as unsuccessful in demonstrating consistent
statistical improvement. Changes in this patient population may have been more
significant if the sample size was larger and the project conducted over a longer time
frame. One possible reason survey changes were not significant is self report biases.
However an unexpected change was a decrease in blood pressure. While blood pressure
was measured at each visit, it was only discussed in global terms.
As hypertension is a significant comorbid condition for diabetics, recent group
medical visits have focused on this metabolic marker. Both Edelman et al. (2010) and
Turchin, Goldberg, Shubina, Einbinder, and Conlin (2010) demonstrated the positive
effect group medical visits had on hypertensive patients. While guidelines identify the
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need for consistent follow up, there is a lack of information on optimal time between
visits. However in a recent study funded by the Agency for Healthcare Research and
Quality, Turchin et al. found that for patients with both hypertension and diabetes, shorter
encounter intervals were associated with an accelerated rate of decrease in blood pressure
when compared with longer encounter intervals. For patients seen at one month or less it
took 1.5 months to normalize while those seen at greater than one month took 12.2
months to normalize.
Attendance. One limitation of this evidence based project was attendance was
not consistent. The sample size was small and any missed visit was very obvious. The
attendance at the first group medical visit started off strong with nine attending. As the
visits progressed, attendance at most was five. For the last visit only three attended.
Originally five had confirmed attendance but at the last minute one participant had to
work and another was going out of town and left a day earlier than expected. At the first
visit, all expressed interest in attending. The group medical visit day and time was
negotiable yet by consensus it remained the third Thursday, 1:30 – 3:30. Two
participants, who were currently employed, felt it would not be a problem in getting off
work. At the close of the first visit, two participants said they would not be able to
attend the following visit due to scheduling conflicts (vacation).
There were three participants that attended only one visit. After missing the
second and third visit, when called to remind them of up coming visits, the absent
patients were asked if they were going to return and one had a work schedule change and
was not able to get off, another started a volunteer project and was needed on Thursdays.
The third patient moved across town and had a transportation issue. In general,
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attendance at group medical visits has been identified variably. Barud et al., (2006)
found attendance rates to be between 40 to 60% for each visit and approximately 50%
returned for a follow up visit. In contrast, prepared from previous experience with group
medical visits, Edelman et al. (2010) was able to gain higher attendance rates by using an
attendance contract, having a consistent care team and by providing a transportation
stipend.
Participants. This homogeneous group of patients represented the practice
demographics. Even though this group consisted of mixed sex there was a lack of
diversity. All participants were Caucasian, represented a population that is relatively well
educated and of middle class which is different than found in literature (Clancy, Cope,
Magruder, Huang, Salter, et al., 2003; Trento et al., 2004). The generalization of the
results may be limited when compared to other more heterogeneous populations.
Considering the majority of past studies have occurred in teaching hospital settings or
indigent clinics, it is possible this group did not feel they needed to attend as they have
many resources including the ability to read, access to on-line information and are able to
pay for needed services.
Medication. During the course of this project, two patients had medication
adjustments as their glucose and A1C levels were significantly elevated. By virtue of this
change in therapy, the group medical visit was not pure in the sense that it was the only
new intervention making it more difficult to tell if the improvements were from the
increase in medication or a change in self management behaviors. In comparison some
groups adjusted medications as part of the group medical visit (Taveira et al., 2010).
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Limited resources. For this project in a single office, the opportunity to have a
multidisciplinary team was limited. In many studies, group medical visits have been
conducted by large centers and university hospital settings where the availability of
multidisciplinary teams are more likely to occur. Barud et al., (2006) found it beneficial
to have clinical pharmacists to assist with education. In other institutions, medical
residents and diabetes educators are a part of the care team (Yu & Beresford, 2010).
Implications for Future Practice
The implementation of this evidence based project was on a much smaller scale
than has been identified in the literature. Even with its shorter time frame and smaller
attendance rate, the results while mixed are indicative of moving in the right direction.
While all improved or maintained diabetes control it was disappointing there was no
weight loss. There are many studies that have demonstrated the positive benefits of group
medical visits including increased provider access, increased provider and patient
satisfaction, increased compliance with ADA recommendations and decreased
emergency department visits (Tsang, Lee, Reddy, & Maskarinec, 2010; Clancy et al.,
2007; Clancy, Cope, Magruder, Huang, & Wolfman, 2003). Findings from this project
with this sample size and type provide information that can be used to implement other
group medical visits.
In retrospect I found I learned a lot implementing group medical visits. My initial
goal was to see if group medical visits were a method to motivate patients to make
positive changes to improve their health status. However I think I learned just as much as
participants. I spent many hours in preparation of each visit, researching and preparing
content. I was concerned I would run out of material and have time left. Interestingly
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this never happened as participants were engaged in discussion and had pertinent
questions. I found providing this type of visit suited my personality. I like to teach and
talk to patients so to have the time to do this and not feel rushed was a win – win for all.
I had the opportunity to provide information and participants had the benefit of attending
monthly and each visit was the equivalent of three to four individually scheduled visits.
Another thing learned from this project was the group composition can be defined
by the time of day and when it occurs. For example this group with the exception of one
was all retired. Coming in and completing the visit during the early afternoon before
rush hour traffic started was important to them. For others working during the day, an
evening timeframe would have been more of interest and for those with children, maybe
a Saturday morning would have been their choice.
In planning for future group medical visits I would like to consider offering them
on a rotating basis. For example schedule the visit during the daytime mid week and
then repeat the same content the following week in the evening or Saturday morning.
Participants could come to which ever time frame suited them. I recognize beforehand
the groups may not be as cohesive however as attendance was a problem, this would offer
the opportunity to still attend.
Recommendations
Diabetes is not a stand alone disease of one person and all people with the disease
do not live alone. For patients to successfully self manage, a tremendous amount of
support is needed particularly from household members and family. Inviting family and
or significant others to the group medical visits may be beneficial so all hear the same
message. This is particularly true if the patient is not the one purchasing the groceries
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and preparing the meals. Patterson and Garwick (1994) identified that major stressful
events, such as chronic illness, affect the family and not just the individual. Therefore
including family or significant others in group medical visits may increase self
management behaviors. Peer and social support are associated with better health.
Chlebowy, Hood, and Lajoie (2010), in their study of facilitators and barriers for selfmanagement of type 2 diabetes, identified both family and peer support as vital to
success.
Another tool to provide reinforcement and support is the use of automated
telephone self-management support (ATSM) systems. In a recent study comparing the
use of usual care, group medical visits and ATSM, Schillinger, Handley, Wang, and
Hammer (2009) found both ATSM and group medical visits were superior to usual care.
However when compared directly to group medical visits, the ATSM had improved self
management behaviors. A disappointing factor was the lack of a difference in A1C
results. As this study was conducted with a vulnerable patient population, it is suggested
it be repeated with a different patient population to see if it will have the same success.
The internet has become ‘the place’ for people seeking healthcare information and
support services (LaCoursiere, 2001). An added tool would be the addition of a computer
mediated communication for group medical visit participants. The purpose would be to
provide education, continued support, encouragement and motivation between group
medical visits (Funnell & Anderson, 2003). White and Dorman (2001) identified online
groups as a useful adjunct to supplement group meetings. An electronic message could
be sent on a regular basis along with a forum where participants would have the
opportunity to ask questions instead of having to wait for the formal group medical visit.
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For me personally, offering group medical visits definitely was a positive
improvement over individually scheduled visits. I prefer not to be rushed and have the
time to talk with patients to make sure they understand what goals we are trying to
accomplish and how we should proceed. With group medical visits it is much easier to
get to know your patients. It offers the opportunity to talk in an unhurried manner and I
feel that as a nurse practitioner I should know my patients and what is influencing them
or will motivate them. In view of today’s reimbursement issues in private practice, it is
necessary that as healthcare providers we use our time wisely and I firmly believe group
medical visits offers the time to effectively treat patients.
Conclusion
When I started this project I was not sure what to expect. I knew what I thought
should happen but never having attended a group medical visit I was a bit uncertain and
even nervous. At the first visit when participants arrived and even though I had talked
with a few on the phone, all were rather quiet and not even talking to each other. This
increased my nervousness. Then once I started, I forgot about being nervous and I
remembered why I was there (not just graduation) and things seemed to click and come
together. At subsequent visits participants were more talkative and I felt like they wanted
to be there as they would come early and after would linger socializing with one another
while the room was straightened up. At the conclusion of the visits, one participant when
asked if he would again participate in group medical visits, said to call him no matter
what day or topic and he would be there. He felt he learned a lot and while he was not
able to do everything, it was making a difference for him.
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Not a week goes by without something in the news about the effects of type 2
diabetes. This chronic illness requires diligence to self-manage and reduce the enormous
risk of complications. While group medical visits offer participants many benefits that
promote self-management behaviors in a supportive atmosphere there is still need to
further evaluate this health care delivery method especially in private practice. Group
medical visits may offer an opportunity to motivate patients to make necessary behavior
changes (Antonucci, 2008). However while promising, Riley and Marshall (2010) noted
“there is not a recognized best structure for a group visit” (p. 937) and “more research is
needed to develop comprehensive models that consistently improve glycemic control and
reduce complications” (p. 943). At this time compared with individual visits, seeing
patients in group medical visits is a more efficient manner to deliver care that helps
promotes self-management behaviors that reduce the risk of complication.
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Appendix A: Sample Letter to Potential Participants
Dear________________
You are invited to participate in a new way of providing medical care for six
months for patients with type 2 diabetes. At this time we are offering group visits instead
of individual office visits. This program is designed specifically with you in mind.
Usually when you come into the office, you are ill or have a specific issue we need
to address. In these short individual visits there is little time to discuss at length how to
manage your diabetes. We recognize diabetes is primarily a self managed process and we
want to give you the information and tools to be successful. These group visits will
replace individual visits unless there are other issues that need to be addressed between
you and your doctor.
The program we are talking about is called Group Medical Visits. It is when
patients with same diagnosis meet together on a regular basis (once a month) with their
medical provider. Many studies have shown that by participating in group visits, you can
increase your success in making lifestyle changes. Attached is a sample agenda so you
can see the flow of the visit. The purpose is to improve your health. In the group we will
discuss a variety of ways to maintain or improve your heath and make sure you are up to
date with all of the yearly American Diabetes Association recommendations.
Occasionally we may even have a guest speaker. This is your opportunity to learn how to
care for yourself and prevent problems.
This is a nursing doctoral project looking to recruit patients with type 2 diabetic
with an A1C >7.5%. Patients who are terminally ill, immobile, have mental or memory
problems, are severely hearing impaired, or who are non English speaking will be
excluded. Patients may be taking oral diabetes medication(s) and/or basal insulin.
Patients with other medical problems may attend.
The first Group Medical Visit will be held April 22, 2010 from 1:30 – 3:30. If you
are interested, please call the office and speak with the medical assistant assigned to this
project to make the appointment. If you have any additional questions or concerns, please
contact Theresa Pye, principal investigator at
or email at
We look forward to hearing from you.
Sincerely

Anne Waldron MD
Theresa Pye ARNP
Doctoral Student
University of North Florida
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Appendix B: Group Medical Visit Information Packet

FAQS ABOUT GROUP MEDICAL VISITS

What are Group Medical Visits?
Group Medical Visits are a combination of three types of visits: individual, education,
and support. Patients attending traditional visits are scheduled for a limited time to
address generally one issue while participants attending Group Medical Visits are
scheduled for approximately 2½ hours. During this time they will go through the same
check in process and have a brief private evaluation to monitor progress and receive
individual information. An education topic will be presented or there may be a guest
speaker such as a dietician or certified diabetes nurse educator. There will be plenty of
time for questions and answers as well as time for some socialization with the group.

What are the benefits of attending Group Medical Visits?
For patients attending Group Medical Visits some of the benefits include they are given
ample time and opportunity with a medical provider and are surrounded by peers who are
coping with the same disease and many of the same issues. Studies have found patients
who attend group medical visits have:
- Increased patient satisfaction
- Improved control of disease, improved health behaviors, improved labs, weight loss
- Improved quality of life, decrease in emergency and subspecialist visits
- Improvement in meeting ADA standards such as eye & podiatry exams, immunizations
How often will they meet?
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Group Medical Visits will meet monthly on the same day and same time. Monthly
attendance is encouraged.

What are some of the reasons to consider switching from traditional visits to Group
Medical Visits?
- Access to Provider Increased
- Power of Group Support
- Patient Satisfaction Increased
- Self-Management Promoted
- Preventive Issues Addressed

Is there a fee to attend Group Medical Visits?
Group visits will be billed as individual office visits appropriate to the level of care
provided, not for time spent. Your fee will include the usual copay required for
individual office visits. If there is a problem meeting this, please speak with the medical
assistant.
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GROUP VISIT GROUND RULES
• Attend meetings and be on time so meetings can start and end on time.
• Respect each others’ privacy. It is ok to discuss what you have learned in these
sessions but don’t mention anyone’s name outside this group.
• Respect each other’s opinions. Be accepting and supportive rather than judgmental.
• Ask questions if you do not understand.
• Listen carefully to others.
• Be an active participant. Also allow everyone to have a chance to speak and / or ask
questions.
• No side conversations. Everyone can’t talk at the same time. Please turn off cell
phones.
• ___________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________
Welcome we are glad you are here today!
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AGENDA FOR THE FIRST SESSION OF GROUP MEDICAL VISIT
Welcome / Introductions
Present Overview / Philosophy of Program
Traditional Visits versus Group Visits
Establish Ground Rules for Group Visits
Privacy and Confidentiality Statements
Reinforce HIPPA
Elicit Patients Primary Concerns
Establish Topic Calendar
Patient Responsibilities
Discuss Patient Report Card
Next Visit
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Appendix C: Assessment Data
Baseline Demographic Data
Participant Number:
Date:
Date of birth:
Sex:
Race:
Martial status:
Highest level of education:
Type of Insurance:
Occupation:

Monthly Data
Variable
Date
Weight
BMI
Waist
B/P
H/R
R/R
BG
HgbA1C

1st Month

2nd Month

3rd Month

4th Month

5th Month

6th Month
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Appendix D: Group Medical Visit Agenda

Group Medical Visit Agenda
Check In
Vital Signs / Blood Glucose
Brief Individual Evaluation

30 minutes

Brief Warm Up / Socialization
Introductions / Welcome

15 minutes

Patient Education Segment
Topic of the Month

30 minutes

Break

15 minutes

Discussion / Q & A

30 minutes

Planning / Wrap Up / Closing

15 minutes

Provider Discretionary Time

15 minutes

Potential Topics
Type 2 Diabetes Disease Process and Treatment Options
Diabetes Numbers At-a-Glance / What do the Numbers Mean?
Diet / Healthy Eating for People with Diabetes
Physical Activity / Get Moving
Foot Care / Preventing Diabetes Foot Problems
Managing Complications
ADA Recommendations
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Appendix E: Patient Report Card

Appendix F

Patient Survey Scales

Appendix F: Diabetes Self Management Surveys
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Appendix F: Diabetes Self Management Survey
Eating Breakfast
1. How many times last week did you eat breakfast when you got up?
____________________ times last week
2. This morning, did you eat any of the following foods for breakfast? (Please check all that
apply) milk (½ cup) cheese yogurt eggs meat, poultry, or fish beans
If you ate anything else, please write here:
_____________________________________________________________________
Glucose Testing
1. Do you have a machine to measure your blood sugar (glucose) level?

Yes

No

2. On how many days in the last week did you test your blood sugar level? (If you were sick in
the last week, think of the most recent 7 days when you were NOT sick) _________ days
Exercise Behaviors
During the past week, even if it was not a typical week for you, how much total time (for the
entire week) did you spend on each of the following? (Please circle one number for each
question.)

Stretching or strengthening exercises
(range of motion, using weights, etc.)

None

Less than
30 min/wk

30-60
min/wk

1-3
hrs/wk

More than
3 hrs/wk

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

Swimming or aquatic exercise

Bicycling (including stationary
exercise bikes)
Other aerobic exercise equipment
(stairmaster, rowing, skiing machine,
etc.)
Other aerobic exercise
Specify:
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Communication with Provider
When you visit your medical provider, how often do you do the following (please circle one
number for each question):
Never Almost Some- Fairly
Very Always
Never
times
Often
Often
Prepare a list of questions for your provider
0
1
2
3
4
5
Ask questions about the things you want to
5
0
1
2
3
4
know and things you don’t understand about
your treatment
Discuss any personal problems that may be
related to your illness
0
1
2
3
4
5
Self-Efficacy for Diabetes
We would like to know how confident you are in doing certain activities. For each of the following
questions, please choose the number that corresponds to your confidence that you can do the tasks
regularly at the present time.
Not At All Confident
Totally Confident

How confident do you feel that you can eat
your meals every 4 to 5 hours every day,
including breakfast every day?
How confident do you feel that you can follow
your diet when you have to prepare or share
food with other people who do not have
diabetes?
How confident do you feel that you can choose
the appropriate foods to eat when you are
hungry (for example, snacks)?
How confident do you feel that you can
exercise 15 to 30 minutes, 4 to 5 times a week?
How confident do you feel that you can do
something to prevent your blood sugar level
from dropping when you exercise?
How confident do you feel that you know what
to do when your blood sugar level goes higher
or lower than it should be?
How confident do you feel that you can judge
when the changes in your illness mean you
should visit the doctor?
How confident do you feel that you can control
your diabetes so that it does not interfere with
the things you want to do?

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10
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Appendix G: Informed Consent

UNIVERSITY OF NORTH FLORIDA
Human Research Consent Form

Title: Impact of Group Medical Visits for Adult Patients with Type 2 Diabetes Mellitus
Investigators: Theresa Pye MSN, ARNP-BC
Affiliations:

University of North Florida School of Nursing

Contact Information:
Approved By Institutional Review Board:

This is an important form. Please read carefully. It tells you what you need to know
about this research study. If you agree to take part in this study, you need to sign
this form. Your signature means that you have been told about the study and what
the risks are. Your signature on this form also means that you want to take part in
this study.
Your participation in this research is entirely voluntary. Refusal to participate in
this research will involve no penalty or loss of benefits to which you otherwise are
entitled.
You may discontinue participation in this research study at any time without
penalty or loss of benefits you are otherwise entitled to.

What is the purpose of this study? As part of my doctoral studies in nursing at the
University of North Florida I am interested in assisting people with diabetes in the
management of their disease. The purpose of this project is to see if group medical
visits for adults with type 2 diabetes improve their ability to manage their diabetes.
How many participants will take part in this study?
Eight patients at this medical office will participate in this project

What will happen in this study?

60
If you agree to participate in this project, you will be receiving your diabetes
medical care during a group session rather than in an individual visit with your
provider. Other medical issues, acute problems and annual exams will not be
addressed during the group medical visits, but will need to be scheduled as
individual appointments.
During the six month project period, your regular diabetes care will continue. Each
visit will consist of check in, a patient education segment, questions and answers,
and planning for next visit.
When you first begin the group medical visits, your hemoglobin A1C blood level will
be checked, you will be weighed, have your waist circumference measured and be
asked to complete a questionnaire about your diabetes self-management activities.
Once a month after that, at each group medical visit, you will be weighed and have
your waist circumference measured.
Three months into the project. Your hemoglobin A1C blood level will be drawn
again [at your usual lab.]
At the end of the project, your hemoglobin A1C blood level will be drawn again [at
your lab] and you will be asked to complete the questionnaire about your diabetes
self-management activities.
Is there any reason I would not be qualified to participate in the study?
This project is looking to recruit patients with type 2 diabetic with an A1C >7.5%.
Patients who are terminally ill, immobile, have mental or memory problems, are severely
hearing impaired, or who are non English speaking will be eligible. Patients may be
taking oral diabetes medication(s) and/or basal insulin. Patients with other medical
problems may attend.
How long will I be in the study?
The group medical visits will occur once a month for six months. Each group
medical visit will last approximately 2 ½ hours
Are there reasons I might leave the study early?
Taking part in this study is your decision. You may decide to stop at any time. You
should tell the director of the study that you wish to stop. In addition, the director of
this study may stop you from taking part if it is in your best interest.
What are the risks of the study?
There are minimal risks or discomforts related to participating in this project. You
will receive routine diabetes care. Sometimes people in groups feel a little
embarrassed at first and fear a loss of privacy, but this embarrassment usually goes
away quickly. If you are in group care and remain uncomfortable in the group
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setting, you will be offered the opportunity to withdraw from the group and receive
individual diabetes care.
Are there benefits to taking part in this study?
Patients attending group medical visits have been found to have an increased
knowledge and ability to problem solve regarding diabetes. There is increased
frequency of self monitoring, and increased adherence of American Diabetes
Association’s Standards of Care.
What other choices do I have if I do not take part in this study?
If you choose not to participate in the group medical visits, you will continue with
individual medical appointments for your diabetes care.
Are there any monetary or other compensation or inducements for my taking part in this
subject?
None
Are there any financial costs to me to take part in this study?
Since the only difference in the care provided through the group medical visits is the
group itself, there are no additional costs to you for receiving your diabetes care this
way. Your insurance will be billed as usual for this care. In the event that your
insurance does not pay for something associated with the project, the medical
practice will forgo those fees. In either case, you will be responsible for the usual copay.
What are my rights if I take part in this study?
You do not have to take part in this study; but if you do, you may stop at any time.
You will be told of important new findings or any changes in the project or
procedures that may affect you. You do not give up any of your rights by taking
part in this project .
What about confidentiality?
Data from this project may be published or used in publications. However, your
name and other identifying information will not be sent outside of UNF without
your written permission.
Explain your method further
Each person will be required to sign a confidentiality agreement before and at each
visit as a reminder. The confidentially statement recognizes all medical and
personal information is confidential and that while they may discuss what was
learned they should never discuss any information about individual group
participants.
Will there be audiotaping or videotaping? If so, will I get to view them before they are
used? Who will review tapes besides the researchers? Who will have access to the tapes?
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When will they be destroyed? (Note – If tapes are to be used outside of the research
project, a separate release form should be obtained.)
There will be no audiotaping or videotaping during the project.
Who can answer my questions?
You may talk to Theresa Pye - Principal Investigator at any time about questions
and concerns you may have about this study. You may contact Theresa Pye at
You may also contact Dr. Doreen Radjenovic, my Faculty
Advisor at the University of North Florida
You may get further information about UNF policies, the conduct of this project ,
and your rights as a project participant from the Chair of the Institutional Review
Board, Dr. Katherine Kasten, at

I have had an opportunity to have my questions answered. I have been given a copy of
this form. I agree to take part in this study. I am over 18 years of age.
I am at least 18 years old.

(initials)

I have had the study that I am agreeing to participate in explained to me to my
satisfaction.
(initials)
I have had the opportunity to ask any questions that I may have had regarding this study.
(initials)
I agree to participate in Impact of Group Medical Visits for Adult Patients with Type 2
Diabetes Mellitus being conducted by Theresa Pye
and the University of North
Florida.

__________
Date

_______________________________________
Printed Name of Participant
________________________________________
Signed Name of Participant

_________
Date

_______________________________________
Printed Name of Individual Obtaining Consent

________
Date

______________________________________
Signed Name of Individual Obtaining Consent
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CONSENT TO ATTEND GROUP MEDICAL VISITS
I, hereby, voluntarily consent to participate in a Diabetes Group Medical Visit in which I
and other patients may share personal health information, if they wish on a purely
personal basis during a Group Medical Visit. The information will be used to help
educate the group about various health topics and which may improve my care. I have
been provided information on the process and understand this is a medical visit. The
group visit may replace some of my routine visits but I will still have some individual
visits.
The group meeting will consist of discussions of current medical conditions, pertinent
educational information, and open discussion with other patients on diabetes and other
subjects of interest to the group. I realize have the option of being seen individually and
may return to individual visits at any time.

Name _______________________________

Signature_____________________________

Witness_______________________________

Date____________________
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Appendix H: Confidentiality Statement
GROUP MEDICAL VISIT HIPPA NOTICE
All patients have the right of privacy and confidentiality regarding their medical record. I
agree to meet with Group Medical Visits and understand I must respect the privacy of
members and therefore while I may discuss what I have learned I must not discuss any
other patient’s medical information or personal business that I may be privileged to hear.
At times, members may voluntarily share information that will be used to help educate
the group on various health topics and which may improve my care.
It is possible that information discussed may be inadvertently disclosed outside of the
Group Medical Visit by another member. I have been notified of this risk of potential
disclosure and I wish to participate in a group medical visit. I realize I have the option of
being seen individually and may return to individual visits at any time.

Name________________________________

Signature______________________________

Witness________________________________

Date____________________
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